Skip to main content
Top

05-05-2017 | Systemic lupus erythematosus | Review | Article

Oral Ulcers in Juvenile-Onset Systemic Lupus Erythematosus: A Review of the Literature

Journal: American Journal of Clinical Dermatology

Authors: Pongsawat Rodsaward, Titipong Prueksrisakul, Tawatchai Deekajorndech, Steven W. Edwards, Michael W. Beresford, Direkrit Chiewchengchol

Publisher: Springer International Publishing

Abstract

Oral ulcers are the most common mucosal sign in juvenile-onset systemic lupus erythematosus (JSLE). The ulcers are one of the key clinical features; however, the terminology of oral ulcers, especially in JSLE patients, is often vague and ill-defined. In fact, there are several clinical manifestations of oral ulcers in JSLE, and some lesions occur when the disease is active, indicating that early management of the disease should be started. Oral ulcers are classified as lupus erythematosus (LE) specific, where the lesional biopsy shows a unique pattern of mucosal change in LE, and LE nonspecific, where the ulcers and their histopathological findings can be found in other oral diseases. Here, the clinical manifestations, diagnosis and management of oral ulcers in JSLE patients are reviewed.
Literature
1.
Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am. 2012;59(2):345–64. doi:10.​1016/​j.​pcl.​2012.​03.​007.CrossRefPubMedPubMedCentral
2.
Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheumatic diseases clinics of North America. 2002;28(3):561–77, vi–vii.
3.
Li C, Wang B, Zhang J, Tan X. Clinical features, treatment and follow-ups of childhood systemic lupus erythematosus. Zhonghua yi xue za zhi. 2014;94(41):3259–61.PubMed
4.
Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. 2011;20(13):1345–55. doi:10.​1177/​0961203311416694​.CrossRefPubMed
5.
Tarr T, Derfalvi B, Gyori N, Szanto A, Siminszky Z, Malik A, et al. Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus. 2015;24(8):796–803. doi:10.​1177/​0961203314563817​.CrossRefPubMed
6.
Lehman TJ, McCurdy DK, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics. 1989;83(2):235–9.PubMed
7.
Huang JL, Yeh KW, Yao TC, Huang YL, Chung HT, Ou LS, et al. Pediatric lupus in Asia. Lupus. 2010;19(12):1414–8. doi:10.​1177/​0961203310374339​.CrossRefPubMed
8.
Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86. doi:10.​1002/​art.​34473.CrossRefPubMedPubMedCentral
9.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi:10.​1002/​1529-0131(199709)40:​9<1725:​AID-ART29>3.​0.​CO;2-Y.CrossRefPubMed
10.
Chiewchengchol D, Murphy R, Edwards SW, Beresford MW. Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. Pediatr Rheumatol Online J. 2015;13:1. doi:10.​1186/​1546-0096-13-1.CrossRefPubMedPubMedCentral
11.
Chiewchengchol D, Murphy R, Morgan T, Edwards SW, Leone V, Friswell M, et al. Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. Rheumatology. 2014;53(8):1504–12. doi:10.​1093/​rheumatology/​keu137.CrossRefPubMed
12.
Ramirez Gomez LA, Uribe Uribe O, Osio Uribe O, Grisales Romero H, Cardiel MH, Wojdyla D, et al. Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. Lupus. 2008;17(6):596–604. doi:10.​1177/​0961203307088006​.CrossRefPubMed
13.
Supavekin S, Chatchomchuan W, Pattaragarn A, Suntornpoch V, Sumboonnanonda A. Pediatric systemic lupus erythematosus in Siriraj Hospital. J Med Assoc Thailand = Chotmaihet thangphaet. 2005;88(Suppl 8):S115–23.
14.
Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschenes G, Kone-Paut I, et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr. 2005;146(5):648–53. doi:10.​1016/​j.​jpeds.​2004.​12.​045.CrossRefPubMed
15.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7.CrossRefPubMed
16.
Nico MM, Vilela MA, Rivitti EA, Lourenco SV. Oral lesions in lupus erythematosus: correlation with cutaneous lesions. EJD. 2008;18(4):376–81. doi:10.​1684/​ejd.​2008.​0388.PubMed
17.
Khatibi M, Shakoorpour AH, Jahromi ZM, Ahmadzadeh A. The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus. Lupus. 2012;21(12):1312–5. doi:10.​1177/​0961203312454589​.CrossRefPubMed
18.
Mi C, Rd S. Lupus erythematosus. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill Medical; 2012. p. 1909–25.
19.
Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008;152(4):550–6. doi:10.​1016/​j.​jpeds.​2007.​09.​019.CrossRefPubMed
20.
Choi JH, Park DJ, Kang JH, Yim YR, Lee KE, Lee JW, et al. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. Lupus. 2015;24(12):1342–9. doi:10.​1177/​0961203315591024​.CrossRefPubMed
21.
Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology. 2013;52(12):2108–15. doi:10.​1093/​rheumatology/​ket160.CrossRefPubMed
22.
Gartner LP. Oral anatomy and tissue types. Semin Dermatol. 1994;13(2):68–73.PubMed
23.
Squier CA, Kremer MJ. Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr. 2001;29:7–15.CrossRef
24.
Woo S-B. Biology and pathology of oral cavity. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill Medical; 2012. p. 827–51.
25.
Burge SM, Frith PA, Juniper RP, Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol. 1989;121(6):727–41.CrossRefPubMed
26.
Ramakrishna Y, Reddy JS. Systemic lupus erythematosus presenting with oral mucosal lesions—a case report. J Clin Pediatr Dent. 2009;33(3):255–8.CrossRefPubMed
27.
Schiodt M, Pindborg JJ. Oral discoid lupus erythematosus. I. The validity of previous histopathologic diagnostic criteria. Oral Surg Oral Med Oral Pathol. 1984;57(1):46–51.CrossRefPubMed
28.
Schiodt M, Halberg P, Hentzer B. A clinical study of 32 patients with oral discoid lupus erythematosus. Int J Oral Surg. 1978;7(2):85–94.CrossRefPubMed
29.
Guillet G, Constant D, Cales D, Helenon R. Cheilitis and labial lesions of lupus in the French Indies. Int J Dermatol. 1985;24(1):66–7.CrossRefPubMed
30.
Neville BW, Damm DD. Dermatologic diseases. In: Neville BW, editor. Oral and maxillofacial pathology. 3rd ed. St. Louis: Saunders/Elsevier; 2009. p. 690–760.
31.
Andreasen JO. Oral Manifestations in discoid and systemic lupus erythematosus. I. Clinical investigation. Acta odontologica Scandinavica. 1964;22:295–310.CrossRefPubMed
32.
Orteu CH, Buchanan JA, Hutchison I, Leigh IM, Bull RH. Systemic lupus erythematosus presenting with oral mucosal lesions: easily missed? Br J Dermatol. 2001;144(6):1219–23.CrossRefPubMed
33.
Nico MM, Lourenco SV. Hypertrophic (verrucous) cutaneous lupus erythematosus of the lip and oral cavity: a series of 4 cases. Acta Dermato-venereologica. 2013;93(1):108–9. doi:10.​2340/​00015555-1433.CrossRefPubMed
34.
Chi AC, Neville BW, Krayer JW, Gonsalves WC. Oral manifestations of systemic disease. Am Fam Physician. 2010;82(11):1381–8.PubMed
35.
Lourenco SV, de Carvalho FR, Boggio P, Sotto MN, Vilela MA, Rivitti EA, et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol. 2007;34(7):558–64. doi:10.​1111/​j.​1600-0560.​2006.​00652.​x.CrossRefPubMed
36.
Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA, et al. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25(14):1542–50. doi:10.​1177/​0961203316644333​.CrossRefPubMedPubMedCentral
37.
Woo SB, Greenberg MS. Ulcerative, vesicular and bullous lesions. In: Glick M, editor. Burket’s oral medicine. 12th ed. Shelton, Connecticut: People's Medical Publishing House USA; 2015. p. 57–89.
38.
Coulson IH, Marsden RA. Lupus erythematosus cheilitis. Clin Exp Dermatol. 1986;11(3):309–13.CrossRefPubMed
39.
Fujimoto W, Hamada T, Yamada J, Matsuura H, Iwatsuki K. Bullous systemic lupus erythematosus as an initial manifestation of SLE. J Dermatol. 2005;32(12):1021–7.CrossRefPubMed
40.
Anyanwu CO, Ang CC, Werth VP. Oral mucosal involvement in bullous lupus. Arthritis Rheum. 2013;65(10):2622. doi:10.​1002/​art.​38051.PubMedPubMedCentral
41.
Lourenco DM, Gomes RC, Aikawa NE, Campos LM, Romiti R, Silva CA. Childhood-onset bullous systemic lupus erythematosus. Lupus. 2014;23(13):1422–5. doi:10.​1177/​0961203314544187​.CrossRefPubMed
42.
Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral surgery, oral medicine, and oral pathology. 1978;46(4):518–39.CrossRefPubMed
43.
Jaworsky C. Lupus erythematosus. In: Lever WF, Elder DE, Ovid Technologies Inc., editors. Lever’s histopathology of the skin. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
44.
Schiodt M. Oral discoid lupus erythematosus. III. A histopathologic study of sixty-six patients. Oral Surg Oral Med Oral Pathol. 1984;57(3):281–93.CrossRefPubMed
45.
Lourenco SV, Nacagami Sotto M, Constantino Vilela MA, Rodrigues Goncalves de Carvalho F, Rivitti EA, Menta Simonsen Nico M. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of epithelial maturation. Journal of cutaneous pathology. 2006;33(10):657–62. doi:10.​1111/​j.​1600-0560.​2006.​00518.​x
46.
Schiodt M, Holmstrup P, Dabelsteen E, Ullman S. Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia. Oral Surg Oral Med Oral Pathol. 1981;51(6):603–8.CrossRefPubMed
47.
Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370–9.CrossRefPubMed
48.
De Rossi SS, Ciarrocca K. Oral lichen planus and lichenoid mucositis. Dent Clin North Am. 2014;58(2):299–313. doi:10.​1016/​j.​cden.​2014.​01.​001.CrossRefPubMed
49.
Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V Oral lichen planus: clinical features and management. Oral Dis. 2005;11(6):338–49. doi:10.​1111/​j.​1601-0825.​2005.​01142.​x.CrossRefPubMed
50.
Daoud MS, Pittelkow MR. Lichen planus. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill Medical; 2012. p. 296–311.
51.
Firth NA, Rich AM, Radden BG, Reade PC. Assessment of the value of immunofluorescence microscopy in the diagnosis of oral mucosal lichen planus. J Oral Pathol Med. 1990;19(7):295–7.CrossRefPubMed
52.
Kulthanan K, Jiamton S, Varothai S, Pinkaew S, Sutthipinittharm P. Direct immunofluorescence study in patients with lichen planus. Int J Dermatol. 2007;46(12):1237–41. doi:10.​1111/​j.​1365-4632.​2007.​03396.​x.CrossRefPubMed
53.
Khudhur AS, Di Zenzo G, Carrozzo M. Oral lichenoid tissue reactions: diagnosis and classification. Expert Rev Mol Diagn. 2014;14(2):169–84. doi:10.​1586/​14737159.​2014.​888953.CrossRefPubMed
54.
Duncan KO, Geisse JK, Leffell DJ. Epitherial precancerous lesions. In: Goldsmith LA, Fitzpatrick TB, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill Medical; 2012. p. 1261–82.
55.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80. doi:10.​1111/​j.​1600-0714.​2007.​00582.​x.CrossRefPubMed
56.
Schiodt M, Andersen L, Shear M, Smith CJ. Leukoplakia-like lesions developing in patients with oral discoid lupus erythematosus. Acta Odontol Scand. 1981;39(4):209–16.CrossRefPubMed
57.
Usatine RP, Tinitigan R. Nongenital herpes simplex virus. Am Fam Physician. 2010;82(9):1075–82.PubMed
58.
Schiodt M. Oral manifestations of lupus erythematosus. Int J Oral Surg. 1984;13(2):101–47.CrossRefPubMed
59.
Munoz-Corcuera M, Esparza-Gomez G, Gonzalez-Moles MA, Bascones-Martinez A. Oral ulcers: clinical aspects. A tool for dermatologists. Part I. Acute ulcers. Clin Exp Dermatol. 2009;34(3):289–94. doi:10.​1111/​j.​1365-2230.​2009.​03220.​x.CrossRefPubMed
60.
Wang X, Zhang L, Luo J, Wu Z, Mei Y, Wang Y, et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: a randomized, controlled clinical trial. J Clin Pharmacol. 2015;55(11):1221–8. doi:10.​1002/​jcph.​537.CrossRefPubMed
61.
Merola JF, Moschella SL. Overview of cutaneous lupus erythematosus. In: TW P, editor. UpToDate. UpToDate, Waltham, MA. (Accessed on September 20, 2015.).
62.
Brennan MT, Valerin MA, Napenas JJ, Lockhart PB. Oral manifestations of patients with lupus erythematosus. Dental clinics of North America. 2005;49(1):127–41, ix. doi:10.​1016/​j.​cden.​2004.​07.​006.
63.
Lee LA. Cutaneous lupus in infancy and childhood. Lupus. 2010;19(9):1112–7. doi:10.​1177/​0961203310370347​.CrossRefPubMed
64.
Thorbinson C, Oni L, Smith E, Midgley A, Beresford MW. Pharmacological management of childhood-onset systemic lupus erythematosus. Paediatr Drugs. 2016;18(3):181–95. doi:10.​1007/​s40272-016-0170-8.CrossRefPubMed